← Leaderboards
J. Michael Walker
Brown University
$4,028,131
Attributed
$4,028,131
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $348.5K · FY2005–07$500K$375K$250K$125K$0
'05
'06
'07
Funding mix
By agency
NIH$4,348,883 · 6
By mechanism
R01$3,584,843 · 3
P40$386,407 · 2
K02$377,633 · 1
Top collaborators
No co-investigators on record.
Most similar at Brown University
Same institution · by research overlap
- Jonathan D. Kurtis$16,800,696
- Stephen T. McGarvey$18,190,958
- Jessica Scales$115,455
- Constance J Chu$65,480
Others in their field
Top investigators on “Spinal Cord”
- William G Barsan · University Of Michigan At Ann Arbor$41,978,947
- Martyn D Goulding · Salk Institute For Biological Studies$29,923,021
- P. Hunter Peckham · Case Western Reserve University$26,617,663
- Aron S Buchman · Rush University Medical Center$24,245,202
- Mark H Tuszynski · University Of California, San Diego$22,931,521
- Gordon Stewart Mitchell · University Of Florida$21,771,368
Research focus
Spinal CordPainCannabinoidsNeuroanatomyPeriaqueductal Gray MatterElectrophysiologyAnandamideCannabinoid ReceptorNeuronsNeuropharmacologyG ProteinNeuroregulationImmunocytochemistryElectrostimulusAnalgesiaLiquid Chromatography Mass SpectrometryInjection /InfusionHigh Performance Liquid ChromatographyIntravenous AdministrationBrain MappingBiological Signal TransductionC FiberLaboratory RatMicrodialysis
Grant awards (24)
Role of endogenous vanilloids and cannabinoids in pain$311,004
R01 · FY2007 · DA · contact PI
Role of endogenous vanilloids and cannabinoids in pain$37,499
R01 · FY2007 · DA · contact PI
Role of endogenous vanilloids and cannabinoids in pain$320,293
R01 · FY2006 · DA · contact PI
Role of endogenous vanilloids and cannabinoids in pain$340,875
R01 · FY2005 · DA
PAIN MODULATION BY ENDOGENOUS CANNABINOIDS$217,985
R01 · FY2004 · DA
PAIN MODULATION BY ENDOGENOUS CANNABINOIDS$115,238
R01 · FY2004 · DA
LABORATORY PRIMATE NEWSLETTER: PSYCH WELL BEING$65,655
P40 · FY2004 · RR
LABORATORY PRIMATE NEWSLETTER$65,655
P40 · FY2004 · RR
PAIN MODULATION BY ENDOGENOUS CANNABINOIDS$323,520
R01 · FY2003 · DA
NEUROLOGICAL BASIS OF PAIN: ROLE OF CANNABINOIDS$206,961
R01 · FY2003 · NS
LABORATORY PRIMATE NEWSLETTER$66,502
P40 · FY2003 · RR
PAIN MODULATION BY ENDOGENOUS CANNABINOIDS$314,100
R01 · FY2002 · DA
NEUROLOGICAL BASIS OF PAIN: ROLE OF CANNABINOIDS$200,933
R01 · FY2002 · NS
MARIJUANA WITHDRAWAL$125,971
K02 · FY2002 · DA
LABORATORY PRIMATE NEWSLETTER$64,565
P40 · FY2002 · RR
PAIN MODULATION BY ENDOGENOUS CANNABINOIDS$50,000
R01 · FY2002 · DA
PAIN MODULATION BY ENDOGENOUS CANNABINOIDS$305,760
R01 · FY2001 · DA
NEUROLOGICAL BASIS OF PAIN: ROLE OF CANNABINOIDS$261,195
R01 · FY2001 · NS
MARIJUANA WITHDRAWAL$125,971
K02 · FY2001 · DA
LABORATORY PRIMATE NEWSLETTER$62,784
P40 · FY2001 · RR
PAIN MODULATION BY ENDOGENOUS CANNABINOIDS$324,550
R01 · FY2000 · DA
NEUROLOGICAL BASIS OF PAIN: ROLE OF CANNABINOIDS$254,930
R01 · FY2000 · NS
MARIJUANA WITHDRAWAL$125,691
K02 · FY2000 · DA
LABORATORY PRIMATE NEWSLETTER$61,246
P40 · FY2000 · RR